Prevalence of Irritable Bowel Syndrome in Japan, China, and South Korea: An International Cross-sectional Study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Background/Aims: Symptoms of irritable bowel syndrome (IBS), a common gut-brain interaction disorder, deteriorate patients' quality of life and increase medical needs; therefore, IBS represents a significant global burden. The estimated global prevalence is approximately 10%; however, accumulated evidence shows international heterogeneity. In this study, we have described and compared the prevalence of IBS in 3 East Asian countries: Japan (Tokyo and Fukuoka), China (Beijing), and South Korea (Seoul). Methods: We conducted an internet-based cross-sectional survey of the urban population aged > 20 years in the abovementioned countries. We recruited equal numbers of age- (20s-60s) and sex-matched participants (3910 residents). IBS was diagnosed according to the Rome III criteria, and the subtypes were analyzed. Results: < 0.001). Furthermore, 54.9% of patients were male. IBS-mixed was the most prevalent subtype; the prevalence of other subtypes varied. Conclusions: The overall prevalence of IBS in the 3 countries was slightly higher than the global prevalence, and it was significantly lower in China than in Japan and South Korea. IBS prevalence was the highest and lowest among individuals in their 40s and 60s, respectively. Male individuals had a higher prevalence of IBS with diarrhea. Further studies are needed to elucidate the factors associated with this regional heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disruption of the microbiota balance can lead to a reduction in some metabolites and slowed intestinal peristalsis, resulting in the accumulation of indigestible oligosaccharides in the large intestine, which in turn causes symptoms, such as abdominal pain, bloating, and constipation [2].”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functional gastrointestinal disorders and the Rome III process
Drossman, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.008 · Cited by 2,416
Sperber, A. D., Bangdiwala, S. I., Drossman, D. A., Ghoshal, U. C., Simren, M., Tack, J., Whitehead, W. E., Dumitrascu, D. L., Fang, X., Fukudo, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.04.014 · Cited by 2,263
Self-citationGlobal Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Composition, variability, and temporal stability of the intestinal microbiota of the elderly
Claesson, M. J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., Marchesi, J. R., Falush, D., Dinan, T., Fitzgerald, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000097107 · Cited by 1,754
Oka, P., Parr, H., Barberio, B., Black, C. J., Savarino, E. V., & Ford, A. C. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30217-x · Cited by 882 · cited 6×
“4% in China (South Korean data were not shown).(8) IBS prevalence is reported to be higher in young and female individuals.”
InfluentialThe impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781 · cited 1×
“Irritable bowel syndrome (IBS) is a symptom complex involving abdominal pain, bloating, diarrhea, and constipation, and leads to a substantial reduction in quality of life.(1) Although IBS is not lifethreatening, it has significant socioeconomic consequences.”
BackgroundSperber, A. D., Dumitrascu, D., Fukudo, S., Gerson, C., Ghoshal, U. C., Gwee, K. A., Hungin, A. P. S., Kang, J.-Y., Minhu, C., Schmulson, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-311240 · Cited by 554 · cited 4×
“%) in the Middle East and Africa.4 In Asian countries, IBS prevalence ranges from 1.1% in Iran to 21.2% in Japan.”
BackgroundResultInfluentialSelf-citationPalsson, O. S., Whitehead, W., Törnblom, H., Sperber, A. D., & Simren, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.021 · Cited by 461 · cited 1×
“In previous large-scale international population-based studies and meta-analyses, IBS prevalence was reported to be lower in individuals aged 50 years or older than in those younger than 50 years.(4,20,21) This finding is consistent with our results.”
ResultLovell, R. M., & Ford, A. C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.131 · Cited by 412
Costs of Irritable Bowel Syndrome in the UK and US
Maxion-Bergemann, S., Thielecke, F., Abel, F., & Bergemann, R. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624010-00002 · Cited by 263
Cited by
Arif, T. B., Ali, S. H., Bhojwani, K. D., Sadiq, M., Siddiqui, A. A., Ur-Rahman, A., Khan, M. Z., Hasan, F., & Shahzil, M. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002994 · Cited by 50
Liu, J., Lv, C., Yin, M., Zhu, M., Wang, B., Tian, J., Hashimoto, K., & Yu, Y. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003257 · Cited by 59
Chronic constipation and gut microbiota: current research insights and therapeutic implications
Xu, X., Wang, Y., Long, Y., & Cheng, Y. (2024) · Postgraduate Medical Journal · doi:10.1093/postmj/qgae112 · Cited by 32
Low-FODMAP Diet for Irritable Bowel Syndrome: Insights from Microbiome
Zhang, H., & Su, Q. (2025) · Nutrients · doi:10.3390/nu17030544 · Cited by 35
Yang, D., Lyu, C., He, K., Pang, K., Guo, Z., & Wu, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031544 · Cited by 22
Matsuura, N., Kanayama, M., Watanabe, Y., Yamada, H., Lili, L., & Torii, A. (2024) · Nutrients · doi:10.3390/nu16193333 · Cited by 20
Prevalence of Irritable Bowel Syndrome in Saudi Arabia: A Systematic Review and Meta-Analysis
Almasary, M. H., Alkhalifah, K. M., Alotaibi, S. H., Elhefny, M., Alabssi, H., Alaklabi, S. S., Alayed, R. S., Alghamdi, A. A., & Albalawi, A. (2023) · Cureus · doi:10.7759/cureus.45357 · Cited by 19
Epidemiology of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Li, C., Ying, Y., Zheng, Y., Li, X., & Lan, L. (2024) · Epidemiology and Public Health · doi:10.52768/epidemiolpublichealth/1034 · Cited by 15
Prevalence of Irritable Bowel Syndrome in East Asia: Are There Differences Between Countries?
Shin, C. M. (2023) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm23042 · Cited by 8
Guo, X., Cheng, T. Y. D., Xuan, M., Geng, L., Zhou, L., Ouyang, W., Chen, X., Yang, X., Wang, J., Gong, B., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157567 · Cited by 5
Global research states and trends of micro RNA in irritable bowel syndrome: a bibliometric analysis
Chen, H., Xu, Z., Zhao, H., Cao, J., Wang, R., He, J., Nie, R., Jia, J., Yuan, S., Li, Y., et al. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01396-y · Cited by 5
Xiao, Y., Meng, X., Luo, Q., Hou, X., Jin, J., Zhong, X., Gong, W., Li, X., & Chen, M. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251314819 · Cited by 3
Prediction of irritable bowel syndrome by integrating urine metabolites and gut microbiota
Lee, G., Lee, M., Park, S., Pak, J., Bae, S., Kwak, S., Moon, Y.-H., & Son, H.-S. (2025) · Scientific Reports · doi:10.1038/s41598-025-22068-1 · Cited by 3
Lee, J. W., & Kim, N. (2024) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2024.107 · Cited by 2
Kim, Y. S., Lee, J. Y., Kim, J., Kang, S. J., Park, J. H., Kim, H. J., Jang, S.-H., Kim, J.-H., & Oh, J. H. (2024) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm23012 · Cited by 2
Wu, L., Fang, J., Chen, M., & Si, Y.-C. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1820371 · Cited by 2
Mind the Gap: The Realities of Novel Irritable Bowel Syndrome Drug Access in Asian Clinical Practice
Kim, Y. S., Oshima, T., Siah, K. T. H., & Choi, S. C. (2024) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm23183 · Cited by 1
Chen, B., Du, L., Zhang, Y., Cen, M., Luo, L., Xu, M., Kim, J. J., & Dai, N. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000715
郭, 嘉. (2024) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2024.34272
An Intestinal Metabolite Exacerbates Stress-induced Diarrhea
Ishihara, N., Kimura, S., & Hase, K. (2025) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.24-00190-2
Varney, J. E., Madan, J., Halmos, E. P., Krishnasamy, S., Lee, Y. Y., Mustafa, U., Siah, K. T. H., Wu, P.-S., Yao, C. K., & Ghoshal, U. C. (2025) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm25090 · Cited by 1
Kim, Y., Kim, D., Jin, H., Ahn, E., Rodgers, R. F., Bui, É., Lee, G., Kim, J., Moon, Y.-H., Kim, K.-O., et al. (2025) · Healthcare · doi:10.3390/healthcare13232998
Kim, H. K., Kim, H., & Lee, A. (2026) · Internet Interventions · doi:10.1016/j.invent.2026.100905
Rooyen, D. M. V., Cai, M., Nair, B. R., & Talley, N. J. (2026) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2026.2651944
Ahmad, S., Zaman, M., Idrees, N., Gul, R., Aziz, Y., & Ahmad, F. (2026) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v7i3.3757
Qalawa, S. A. A., Elbqry, M. G., Elmansy, F. M., Almunif, A. T., Alharbi, B. F., Alharbi, R. J., Alharbi, J. A., Alharbi, K. M., Almuhaysin, S. A., Almutairi, S. T., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1804238
AL-Shahrani, A. M., Alqarni, A. H., Assem, M., Alaklabi, K. M., Aloqaybi, S. A., Alsherie, M. I., Alsoairi, R. A., Alshahrani, R. A., Algarni, J. K., Elnour, S., et al. (2026) · Journal of Umm Al-Qura University for Medical Sciences · doi:10.1007/s44361-026-00043-3
Older adults with constipation and Parkinson’s disease share comparable gut microbiota
Ke, L., Wang, Y., Tang, L., Yang, M. R., Liu, Q., Wu, J., Bi, X., Chen, Y., & Liu, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1688918
Półchłopek, S., Szpanelewski, K., Kołodziej, R., Kołodziej, A., Lulek, S., Klecha, J., Kucab, E., Dziki, K., Kula, I. K., Ciemięga, J., et al. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5688
Radzka, M., Radzka, I., Budzik, P., Marciszuk, S., Rataj, J., Bawor, M., & Kosowska, A. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(52).2026.6255
Metadata
- Authors
- Takeoka, A., Kimura, T., Hara, S., Hamaguchi, T., Fukudo, S., & Tayama, J.
- Affiliations
- Nagasaki University (JP)
- Kyushu University (JP)
- Kyoto Tachibana University (JP)
- Saitama Prefectural University (JP)
- Tohoku University (JP)
- Waseda University (JP)
- Corresponding author
- Tayama, Jun
- Venue
- Journal of Neurogastroenterology and Motility
- Published
- 2023-04-30
- Volume
- 29
- Issue
- 2
- Pages
- 229-237
- ISSN
- 2093-0879 (ISSN-L)
- 2093-0887
- PMC
- PMC10083109
- OpenAlex
- W4362638032
- Cited by
- 30
- References
- 33
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 11 · 2023: 2
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- Locations
- Journal of Neurogastroenterology and Motility (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (27819)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- irritable bowel syndrome, prevalence, IBS subtypes, Rome III criteria, gut-brain axis, regional variation, East Asia, Japan, China, South Korea, sex differences, age differences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
